<p>2025 年 11 月 19 日- 上午 09:15</p>
<p>德克薩斯州奧斯汀，2025 年 11 月 19 日（GLOBE NEWSWIRE）-- Astrotech Corporation（納斯達克：ASTC）（“公司” 或 “Astrotech”）今天宣佈，其董事會已啓動戰略選擇的審查，以探索最大化股東價值的方法。該審查將包括一系列潛在行動，包括籌集股本、反向合併、組合交易以及出售公司全部或部分業務，以及其他可能的戰略或財務交易。</p>
<p>“我們對我們獨特的質譜和氣相色譜技術，以及我們為在大型終端市場（如爆炸物痕跡檢測、毒品痕跡檢測、安全篩查、環境測試和工業控制）創造價值而開發的特定終端市場應用保持信心。我們將繼續推進我們的戰略銷售計劃，並與全球客户深化關係。然而，我們也在考慮一些戰略選擇，以便更有效地擴大我們的業務並最大化股東價值，” Astrotech 董事長兼首席執行官 Thomas B. Pickens, III 表示。</p>
<p>Astrotech 尚未設定戰略選擇審查過程的截止日期或明確時間表，無法保證該過程將導致任何交易或特定結果。除非董事會決定進一步披露是適當或必要的，否則公司不打算對此主題進一步評論。</p>
<p><strong>關於 Astrotech Corporation</strong></p>
<p>Astrotech（納斯達克：ASTC）是一家質譜公司，通過其全資子公司創建、運營和擴展創新業務。每個子公司利用 Astrotech 的核心技術為專業市場服務：</p>
<ul>
<li><strong>1st Detect</strong> 開發、製造和銷售用於安全和毒品篩查應用的痕跡檢測系統。</li>
<li><strong>AgLAB</strong> 設計針對農業行業的過程分析儀。</li>
<li><strong>Pro-Control</strong> 生產用於工業製造中的原位化學過程控制的解決方案。</li>
<li><strong>EN-SCAN, Inc.</strong> 提供便攜式、堅固的環境測試解決方案，集成氣相色譜和質譜，適用於具有挑戰性的現場環境。</li>
</ul>
<p><strong>前瞻性聲明</strong></p>
<p>本新聞稿包含根據 1995 年《私人證券訴訟改革法》安全港條款作出的 “前瞻性聲明”。此類前瞻性聲明受到風險、趨勢和不確定性的影響，這可能導致實際結果與前瞻性聲明存在重大差異。這些聲明可能通過 “旨在”、“預期”、“相信”、“考慮”、“繼續”、“可能”、“估計”、“期望”、“預測”、“指導”、“打算”、“可能”、“計劃”、“可能的”、“潛在的”、“預測”、“初步”、“項目”、“尋求”、“應該”、“目標”、“將” 或 “會” 或這些術語的否定形式、這些術語的變體或其他類似表達來識別。這些因素包括但不限於戰略選擇審查過程目標的實現、通貨膨脹壓力的負面影響，包括燃料成本的顯著增加、全球經濟狀況及與這些狀況相關的事件，包括烏克蘭和中東的持續戰爭、公司對普通股發行收益的使用、我們是否能夠成功完成新產品和專有技術的開發、我們是否能夠獲得在美國或國外市場銷售我們正在開發的產品所需的 FDA 和其他監管批准、市場是否會接受我們的產品和服務，以及我們在識別、完成和整合收購方面的成功，以及公司在證券交易委員會的備案文件中描述的其他風險因素和商業考慮，包括公司最近的 10-K 表格年度報告和 10-Q 表格季度報告中的內容。本文檔中的任何前瞻性聲明應根據這些重要風險因素進行評估。雖然我們不打算直接收穫、製造、分銷或銷售大麻或大麻產品，但我們可能會受到聯邦或州政府執法變化的負面影響，並且我們可能會面臨與不斷變化的監管領域及相關不確定性相關的額外風險。這些影響可能會導致當前未知的風險和不確定性，或加劇此處提到的其他風險。儘管公司相信其前瞻性聲明中反映的預期是合理的，並基於合理的假設，但無法保證這些假設是準確的，或這些預期中的任何一項將實現（全部或部分）或證明是正確的。此外，本新聞稿中包含的任何前瞻性聲明僅代表公司在其發佈之日的觀點，不應被視為其在任何後續日期的觀點。公司不承擔糾正或更新這些前瞻性聲明的義務，無論是由於新信息、未來事件還是其他原因，除非適用法律要求。</p>
<p>公司聯繫人：</p>
<p>Scott Bartley</p>
<p>首席財務官，Astrotech Corporation</p>
<p>(512) 485-9530</p>
<p>投資者聯繫人：</p>
<p>Matt Kreps</p>
<p>董事總經理，Darrow Associates</p>
<p>(214) 597-8200 mkreps@darrowir.com</p>
<hr/>
<p><img src="https://imageproxy.pbkrs.com/https://www.globenewswire.com/newsroom/ti/query-bmY9T1RVM09EUTFOU00zTWpjeU1EYzFJelV3TURFd09EQTVPUT09?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.globenewswire.com/newsroom/ti/query-bmY9T1RVM09EUTFOU00zTWpjeU1EYzFJelV3TURFd09EQTVPUT09"/></p>
<p><img src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/media/MzVkYTQyZDYtZDNjZi00OGEzLWExZGUtYTAxMTJjNzg0Y2UwLTUwMDEwODA5OS0yMDI1LTExLTE5LWVu/tiny/Astrotech-Corporation.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/media/MzVkYTQyZDYtZDNjZi00OGEzLWExZGUtYTAxMTJjNzg0Y2UwLTUwMDEwODA5OS0yMDI1LTExLTE5LWVu/tiny/Astrotech-Corporation.png"/></p>

ASTC

<p>Astrotech Corporation 宣佈進行戰略審查，以探索最大化股東價值的選項，包括潛在的股權融資、合併或業務出售。該公司旨在利用其質譜和氣相色譜技術，在安全和環境檢測等大型市場中發揮作用。審查沒有設定截止日期，結果尚不確定。Astrotech 僅在必要時進行更新</p>

<p>11/19/2025 - 09:15 AM</p>
<div class="lb-trans"><p>2025 年 11 月 19 日- 上午 09:15</p>
</div><p>AUSTIN, Texas, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Astrotech Corporation (Nasdaq: ASTC) (the “Company” or “Astrotech”) today announced that its Board of Directors has initiated a review of strategic alternatives in order to explore ways to maximize shareholder value. The review will include a range of potential actions, including raising equity capital, reverse mergers, combination transactions, and the sale of all or part of the Company’s business, and other possible strategic or financial transactions.</p>
<div class="lb-trans"><p>德克薩斯州奧斯汀，2025 年 11 月 19 日（GLOBE NEWSWIRE）-- Astrotech Corporation（納斯達克：ASTC）（“公司” 或 “Astrotech”）今天宣佈，其董事會已啓動戰略選擇的審查，以探索最大化股東價值的方法。該審查將包括一系列潛在行動，包括籌集股本、反向合併、組合交易以及出售公司全部或部分業務，以及其他可能的戰略或財務交易。</p>
</div><p>“We remain confident in our differentiated mass spectrometry and gas chromatography technologies, and in the specific end market applications we have developed to create value in large end markets, such as explosives trace detection, narcotics trace detection, security screening, environmental testing and industrial controls. We continue to move forward with our strategic sales plans and advance relationships with customers around the world. However, we are also looking at strategic options that could allow us to more effectively scale our business and maximize value for our shareholders” said Thomas B. Pickens, III, Astrotech’s Chairman and Chief Executive Officer.</p>
<div class="lb-trans"><p>“我們對我們獨特的質譜和氣相色譜技術，以及我們為在大型終端市場（如爆炸物痕跡檢測、毒品痕跡檢測、安全篩查、環境測試和工業控制）創造價值而開發的特定終端市場應用保持信心。我們將繼續推進我們的戰略銷售計劃，並與全球客户深化關係。然而，我們也在考慮一些戰略選擇，以便更有效地擴大我們的業務並最大化股東價值，” Astrotech 董事長兼首席執行官 Thomas B. Pickens, III 表示。</p>
</div><p>Astrotech has not set a deadline or definitive timetable for the completion of the strategic alternatives review process, and there can be no assurance that this process will result in any transaction or specific outcome. The Company does not intend to comment further on this topic unless and until the Board has determined that further disclosure is appropriate or necessary.</p>
<div class="lb-trans"><p>Astrotech 尚未設定戰略選擇審查過程的截止日期或明確時間表，無法保證該過程將導致任何交易或特定結果。除非董事會決定進一步披露是適當或必要的，否則公司不打算對此主題進一步評論。</p>
</div><p><strong>About Astrotech Corporation</strong></p>
<div class="lb-trans"><p><strong>關於 Astrotech Corporation</strong></p>
</div><p>Astrotech (Nasdaq: ASTC) is a mass spectrometry company that creates, operates, and scales innovative businesses through its wholly owned subsidiaries. Each subsidiary leverages Astrotech’s core technology to serve specialized markets:</p>
<div class="lb-trans"><p>Astrotech（納斯達克：ASTC）是一家質譜公司，通過其全資子公司創建、運營和擴展創新業務。每個子公司利用 Astrotech 的核心技術為專業市場服務：</p>
</div><ul>
<li><strong>1st Detect</strong> develops, manufactures, and markets trace detection systems for security and narcotics screening applications.</li>
<li><strong>AgLAB</strong> designs process analyzers tailored to the agriculture industry.</li>
<li><strong>Pro-Control</strong> produces solutions for in-situ chemical process control in industrial manufacturing.</li>
<li><strong>EN-SCAN, Inc.</strong> delivers portable, ruggedized environmental testing solutions that integrate gas chromatography and mass spectrometry for use in challenging field environments.</li>
</ul>
<div class="lb-trans"><ul>
<li><strong>1st Detect</strong> 開發、製造和銷售用於安全和毒品篩查應用的痕跡檢測系統。</li>
<li><strong>AgLAB</strong> 設計針對農業行業的過程分析儀。</li>
<li><strong>Pro-Control</strong> 生產用於工業製造中的原位化學過程控制的解決方案。</li>
<li><strong>EN-SCAN, Inc.</strong> 提供便攜式、堅固的環境測試解決方案，集成氣相色譜和質譜，適用於具有挑戰性的現場環境。</li>
</ul>
</div><p><strong>Forward-Looking Statements</strong></p>
<div class="lb-trans"><p><strong>前瞻性聲明</strong></p>
</div><p>This press release contains “forward-looking statements” that are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are subject to risks, trends, and uncertainties that could cause actual results to be materially different from the forward-looking statement. These statements may be identified by terms such as “aims,” “anticipates,” “believes,” contemplates,” “continue,” “could,” “estimates,” “expect,” “forecast,” “guidance,” “intends,” “may,” “plans,” “possible,” “potential,” “predicts,” “preliminary,” “projects,” “seeks,” “should,” “targets,” “will” or “would,” or the negatives of these terms, variations of these terms or other similar expressions. These factors include, but are not limited to, achievement of the objectives of the strategic alternatives review process, the adverse impact of inflationary pressures, including significant increases in fuel costs, global economic conditions and events related to these conditions, including the ongoing wars inUkraineand the middle east, the Company’s use of proceeds from the common stock offerings, whether we can successfully complete the development of our new products and proprietary technologies, whether we can obtain the FDA and other regulatory approvals required to market our products under development inthe United Statesor abroad, whether the market will accept our products and services and whether we are successful in identifying, completing and integrating acquisitions, as well as other risk factors and business considerations described in the Company’s Securities and Exchange Commission filings including the Company’s most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. Any forward-looking statements in this document should be evaluated in light of these important risk factors. While we do not intend to directly harvest, manufacture, distribute or sell cannabis or cannabis products, we may be detrimentally affected by a change in enforcement by federal or state governments and we may be subject to additional risks in connection with the evolving regulatory area and associated uncertainties. Any such effects may give rise to risks and uncertainties that are currently unknown or amplify others mentioned herein. Although the Company believes the expectations reflected in its forward-looking statements are reasonable and are based on reasonable assumptions, no assurance can be given that these assumptions are accurate or that any of these expectations will be achieved (in full or at all) or will prove to have been correct. Moreover, such statements are subject to a number of assumptions, risks and uncertainties, many of which are beyond the control of the Company, which may cause actual results to differ materially from those implied or expressed by the forward-looking statements. In addition, any forward- looking statements included in this press release represent the Company’s views only as of the date of its publication and should not be relied upon as representing its views as of any subsequent date. The Company assumes no obligation to correct or update these forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law.</p>
<div class="lb-trans"><p>本新聞稿包含根據 1995 年《私人證券訴訟改革法》安全港條款作出的 “前瞻性聲明”。此類前瞻性聲明受到風險、趨勢和不確定性的影響，這可能導致實際結果與前瞻性聲明存在重大差異。這些聲明可能通過 “旨在”、“預期”、“相信”、“考慮”、“繼續”、“可能”、“估計”、“期望”、“預測”、“指導”、“打算”、“可能”、“計劃”、“可能的”、“潛在的”、“預測”、“初步”、“項目”、“尋求”、“應該”、“目標”、“將” 或 “會” 或這些術語的否定形式、這些術語的變體或其他類似表達來識別。這些因素包括但不限於戰略選擇審查過程目標的實現、通貨膨脹壓力的負面影響，包括燃料成本的顯著增加、全球經濟狀況及與這些狀況相關的事件，包括烏克蘭和中東的持續戰爭、公司對普通股發行收益的使用、我們是否能夠成功完成新產品和專有技術的開發、我們是否能夠獲得在美國或國外市場銷售我們正在開發的產品所需的 FDA 和其他監管批准、市場是否會接受我們的產品和服務，以及我們在識別、完成和整合收購方面的成功，以及公司在證券交易委員會的備案文件中描述的其他風險因素和商業考慮，包括公司最近的 10-K 表格年度報告和 10-Q 表格季度報告中的內容。本文檔中的任何前瞻性聲明應根據這些重要風險因素進行評估。雖然我們不打算直接收穫、製造、分銷或銷售大麻或大麻產品，但我們可能會受到聯邦或州政府執法變化的負面影響，並且我們可能會面臨與不斷變化的監管領域及相關不確定性相關的額外風險。這些影響可能會導致當前未知的風險和不確定性，或加劇此處提到的其他風險。儘管公司相信其前瞻性聲明中反映的預期是合理的，並基於合理的假設，但無法保證這些假設是準確的，或這些預期中的任何一項將實現（全部或部分）或證明是正確的。此外，本新聞稿中包含的任何前瞻性聲明僅代表公司在其發佈之日的觀點，不應被視為其在任何後續日期的觀點。公司不承擔糾正或更新這些前瞻性聲明的義務，無論是由於新信息、未來事件還是其他原因，除非適用法律要求。</p>
</div><p>Company Contact:</p>
<div class="lb-trans"><p>公司聯繫人：</p>
</div><p>Scott Bartley</p>
<div class="lb-trans"><p>Scott Bartley</p>
</div><p>Chief Financial Officer, Astrotech Corporation</p>
<div class="lb-trans"><p>首席財務官，Astrotech Corporation</p>
</div><p>(512) 485-9530</p>
<div class="lb-trans"><p>(512) 485-9530</p>
</div><p>Investor Contact:</p>
<div class="lb-trans"><p>投資者聯繫人：</p>
</div><p>Matt Kreps</p>
<div class="lb-trans"><p>Matt Kreps</p>
</div><p>Managing Director, Darrow Associates</p>
<div class="lb-trans"><p>董事總經理，Darrow Associates</p>
</div><p>(214) 597-8200 mkreps@darrowir.com</p>
<div class="lb-trans"><p>(214) 597-8200 mkreps@darrowir.com</p>
</div><hr/>
<div class="lb-trans"><hr/>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.globenewswire.com/newsroom/ti/query-bmY9T1RVM09EUTFOU00zTWpjeU1EYzFJelV3TURFd09EQTVPUT09" alt="" original-src="https://www.globenewswire.com/newsroom/ti?nf=OTU3ODQ1NSM3MjcyMDc1IzUwMDEwODA5OQ=="/></p>
<p><img src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/media/MzVkYTQyZDYtZDNjZi00OGEzLWExZGUtYTAxMTJjNzg0Y2UwLTUwMDEwODA5OS0yMDI1LTExLTE5LWVu/tiny/Astrotech-Corporation.png" alt="" original-src="https://ml.globenewswire.com/media/MzVkYTQyZDYtZDNjZi00OGEzLWExZGUtYTAxMTJjNzg0Y2UwLTUwMDEwODA5OS0yMDI1LTExLTE5LWVu/tiny/Astrotech-Corporation.png"/></p>

Astrotech 宣佈審查戰略替代方案以最大化股東價值 | ASTC 股票新聞